Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F57CH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,042
Award facts
- Contract value 100% obligated
- $46,042.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $46,042.47 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Dupixent 300 mg/2 ml pen injections. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with a completion date of January 6, 2026. No set-aside designation was applied to this award.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. Dupixent is a biologic immunosuppressant medication primarily indicated for eczema, asthma, and chronic rhinosinusitis, reflecting the Defense Health Agency's procurement of specialty pharmaceutical products through the DLA's global pharmaceutical support vehicle. This delivery order exemplifies the company's ongoing role in fulfilling federal medical supply needs across multiple therapeutic domains, leveraging its established relationship with the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F57CH?
SPE2DR26F57CH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F57CH worth?
The government has obligated $46,042 on SPE2DR26F57CH.
Is contract SPE2DR26F57CH an order under another contract?
Yes. SPE2DR26F57CH is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57CH competed?
The extent of competition for SPE2DR26F57CH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award